Costimulatory pathways in multiple sclerosis

Costimulatory molecules can be categorized based either on their functional attributes or on their structure. The costimulatory molecules discussed in this review will be divided into (1) positive costimulatory pathways: promoting T cell activation, survival and/or differentiation; (2) negative costimulatory pathways:antagonizing TCR signalling and suppressing T cell activation; (3) as third group we will discuss the members of the TIM family, a rather “new” family of cell surface molecules involved in the regulation of T cell differentiation and Treg function. Costimulatory pathways have a critical role in the regulation of alloreactivity.  A complex network of positive and negative pathways regulates T cell responses.  Blocking costimulation improves allograft survival in rodents and non-human primates. The costimulation blocker belatacept is being developed as immunosuppressive drug in renal transplantation.

    Related Conference of Costimulatory pathways in multiple sclerosis

    December 14-15, 2017

    World Immunology Congress

    Dubai, UAE
    May 16-17, 2018

    World Congress on Allergy and Immunotherapy

    Osaka, Japan
    June 14-16 2018

    9th European Immunology Conference

    Rome, Italy
    July 12-13, 2018

    5th International Conference on Parasitology

    Paris, France
    September 13-14, 2018

    Annual Congress on Immunology & Immunotechnology

    Zurich, Switzerland
    October 19-20, 2018

    10th World Congress and Expo on Immunology

    Baltimore, USA
    October 29-30, 2018

    6th International Conference on HIV/AIDS, STDs and STIs

    San Francisco, USA
    November 26-27, 2018

    3rd International Conference on Autoimmunity

    Dublin, Ireland

    Costimulatory pathways in multiple sclerosis Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in